Summary:
Anderson Clinical Research is conducting a Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate
the Efficacy and Safety of AMG 334 in Migraine Prevention.
If you are 18-65 years old and qualify as a Participant for this Clinical Research
Trial, you will receive Clinical Research Study Related Procedures and the
Investigational Study Drug at No Cost to you. You may also receive
Compensation for Time and Travel.